Porter Martina L, Lockwood Stephen J, Kimball Alexa B
Clinical Unit for Research Trials and Outcomes in Skin (CURTIS), Massachusetts General Hospital, Boston, MA.
Department of Dermatology, Harvard Medical School, MA.
Int J Womens Dermatol. 2017 Feb 4;3(1):21-25. doi: 10.1016/j.ijwd.2016.12.003. eCollection 2017 Mar.
Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating.
生物制剂已越来越普遍地用于治疗银屑病患者,但对其对妊娠和哺乳影响的担忧常常使在这些时期无法采用这种治疗方法。在过去十年中,我们对妊娠期间银屑病的病程以及妊娠和哺乳期间使用生物制剂的安全性有了更好的了解。在某些情况下,生物制剂可被视为妊娠或哺乳期患者的合适治疗选择。